Effectiveness of tiotropium in low-risk patients according to new GOLD severity grading

D. Halpin, M. Decramer, B. Celli, A. Martín, I. Leimer, N. Metzdorf, D. Tashkin (Exeter, United Kingdom; Leuven, Belgium; Boston, New York, Los Angeles, United States Of America; Ingelheim, Germany)

Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Session: Translational respiratory medicine in asthma and COPD
Session type: Thematic Poster Session
Number: 2190
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Halpin, M. Decramer, B. Celli, A. Martín, I. Leimer, N. Metzdorf, D. Tashkin (Exeter, United Kingdom; Leuven, Belgium; Boston, New York, Los Angeles, United States Of America; Ingelheim, Germany). Effectiveness of tiotropium in low-risk patients according to new GOLD severity grading. Eur Respir J 2012; 40: Suppl. 56, 2190

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

Health status in the GOLD guidelines era. Assessing the new COPD severity staging criteria
Source: Eur Respir J 2002; 20: Suppl. 38, 251s
Year: 2002

GOLD assessment of COPD patients: Impact of symptoms assessment choice
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

Combined COPD assessment using the new GOLD guidelines
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012




Impact of comorbidities on survival of patients with COPD according to GOLD stages
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011


Relationship between quality of life and severity of COPD according to GOLD classification
Source: Eur Respir J 2004; 24: Suppl. 48, 15s
Year: 2004

The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014


Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017

Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


Adherence to pharmacotherapy of Colombian patients with COPD according to GOLD 2019
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020


Evaluation of prevalence of COPD according to different criteria
Source: Eur Respir J 2002; 20: Suppl. 38, 124s
Year: 2002

10-year cumulative incidence of COPD in a symptomatic cohort using BTS and GOLD spirometric criteria
Source: Eur Respir J 2003; 22: Suppl. 45, 214s
Year: 2003

The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Psychologic impairment according to GOLD COPD staging for patients in a primary care setting
Source: Annual Congress 2007 - Managing COPD in primary care
Year: 2007


Distribution of COPD patients in the GOLD assessment framework by exacerbations
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012

GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Use of GOLD staging as a guide for treating COPD patients in primary care
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011


An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004

Validation of non-spirometric predictors of COPD to the GOLD stage classification
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002